Login / Signup

A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination.

Seok Hyun KimSoo Yong LeeGa Yun KimJi Soo OhJeong Su KimKook-Jin ChunMin Ho JuChee Hoon LeeYeo-Jeong SongJoo Young Na
Published in: Journal of Korean medical science (2022)
Vaccines have become the mainstay of management against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (coronavirus disease 2019; COVID-19) in the absence of effective antiviral therapy. Various adverse effects of COVID-19 vaccination have been reported, including cardiovascular complications such as myocarditis or pericarditis. Herein, we describe clinical records of a 63-year woman with fulminant myocarditis following ChAdOx1 nCoV-19 vaccination that was salvaged by heart transplantation. She complained chest pain, nausea, vomiting, and fever after the second vaccination. After the heart transplantation, the patient died due to necrotizing pneumonia on the 54th day of onset. Fulminant myocarditis is very rare after ChAdOx1 nCoV-19 vaccination but can be fatal.
Keyphrases
  • coronavirus disease
  • respiratory syndrome coronavirus
  • sars cov
  • liver failure
  • risk factors
  • stem cells
  • emergency department
  • bone marrow
  • mechanical ventilation
  • cell therapy